|
Roche Plans Fall Rollout of New Viral Load Test for Transplant Recipients
Roche Molecular Systems is preparing a September launch for the first FDA-approved DNA test to measure viral load of cytomegalovirus (CMV) in solid organ transplant patients undergoing antiviral treatment.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives